Cargando…

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

BACKGROUND: The clinical implementation of pharmacogenomics (PGx) could be one of the first milestones towards realizing personalized medicine in routine care. However, its widespread adoption requires the availability of suitable clinical decision support (CDS) systems, which is often impeded by th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blagec, Kathrin, Swen, Jesse J., Koopmann, Rudolf, Cheung, Ka-Chun, Crommentuijn - van Rhenen, Mandy, Holsappel, Inge, Konta, Lidija, Ott, Simon, Steinberger, Daniela, Xu, Hong, Cecchin, Erika, Dolžan, Vita, Dávila-Fajardo, Cristina Lucía, Patrinos, George P., Sunder-Plassmann, Gere, Turner, Richard M., Pirmohamed, Munir, Guchelaar, Henk-Jan, Samwald, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176797/ https://www.ncbi.nlm.nih.gov/pubmed/35675343 http://dx.doi.org/10.1371/journal.pone.0268534

Ejemplares similares

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020)

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023)

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
por: Monnin, Pierre, et al.
Publicado: (2019)

HUGO Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance
Publicado: (2007)

PGxCorpus, a manually annotated corpus for pharmacogenomics
por: Legrand, Joël, et al.
Publicado: (2020)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
por: Matišić, Vid, et al.
Publicado: (2023)

Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
por: Vermehren, Charlotte, et al.
Publicado: (2020)

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts
por: Just, Katja S., et al.
Publicado: (2019)

Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study
por: Blagec, Kathrin, et al.
Publicado: (2016)

Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
por: Zhai, Song, et al.
Publicado: (2022)

An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care
por: Miñarro-Giménez, Jose Antonio, et al.
Publicado: (2014)

Technologies for Pharmacogenomics: A Review
por: van der Lee, Maaike, et al.
Publicado: (2020)

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
por: Samwald, Matthias, et al.
Publicado: (2016)

PGx: Putting Peptides to BED
por: Askenazi, Manor, et al.
Publicado: (2015)

Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling
por: Chua, Eng Wee, et al.
Publicado: (2016)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines
por: Westergaard, Niels, et al.
Publicado: (2021)

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial
por: Riegersperger, Markus, et al.
Publicado: (2015)

Translating Pharmacogenomics: Challenges on the Road to the Clinic
por: Swen, Jesse J, et al.
Publicado: (2007)

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
por: Schuh, Michael J.
Publicado: (2019)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
por: Koomdee, Napatrupron, et al.
Publicado: (2022)

Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)

Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug–Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients
por: Westergaard, Niels, et al.
Publicado: (2020)

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2014)

Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

PGxMine: Text mining for curation of PharmGKB
por: Lever, Jake, et al.
Publicado: (2020)

Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle
por: van der Lee, Maaike, et al.
Publicado: (2021)

Pharmacogenomics for Primary Care: An Overview
por: Rollinson, Victoria, et al.
Publicado: (2020)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r514id3lrdtngei2jgrj9aalsr